Procyrion Completes $10M Series B

October 12, 2015

Share:

Procyrion has secured a $10 million Series B round led in part by Fannin Partners and Scientific Health Development; Carter Meyer, CEO of Scientific Health Development, will join the company's Board of Directors. Procyrion is developing a catheter-deployed, intra-aortic pump for ambulatory use. The device is designed to rest and heal the heart by reducing afterload, while also improving blood flow to vital organs. To date, Procyrion has raised just north of $13 million in funding.